Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.54
Delayed Data
As of Mar 27
 -0.48 / -6.84%
Today’s Change
3.71
Today|||52-Week Range
14.80
+43.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization28.3K14.7K5.4K6.0K
 
 
 
 
 
 
Operating ExpensesGross Income-28.3K-14.7K-5.4K-6.0K
 
 
 
 
 
General Expenses2.4M2.9M4.3M6.3M
 
 
 
 
 
Research And Development1.1M1.7M2.3M3.7M
 
 
 
 
 
Total Operating Expenses2.4M2.9M4.3M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.4M-2.9M-4.3M-6.3M
 
 
 
 
 
Extraordinary Credit0.000.0044.7K--
 
 
Extraordinary Charge-197.4K-184.3K----
 
 
 
Other Expenses1.0M-199.1K-196.4K504.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-3.3M-4.4M-5.7M
 
 
 
 
 
Income Taxes-24.0K-90.2K-205.1K-4.0K
 
 
 
 
 
Net Income-1.6M-3.3M-4.2M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.4M5.9M7.2M9.2M
 
 
 
 
 
Shares To Calculate EPS Diluted5.4M5.9M7.2M9.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.24-$0.60-$0.59-$0.62
 
 
 
 
 
EPS Diluted-$0.24-$0.60-$0.59-$0.62
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account